Cerebral hyperperfusion syndrome following carotid endarterectomy

Authors

  • Thomas Saliba CHUV Centre Hospitalier Universitaire Vaudois, Rue du Bugnon 46, 1005 Lausanne, Switzerland https://orcid.org/0000-0001-6989-9577
  • Olivier Cappeliez Hopital de Braine L'Alleud, CHIREC Rue Wayez, 35 1420 Braine l'Alleud, Belgium https://orcid.org/0000-0002-0652-1048
  • Henri Maisonnier Hopital de Braine L'Alleud, CHIREC Rue Wayez, 35 1420 Braine l'Alleud, Belgium
  • Sanjiva Pather Hopital de Braine L'Alleud, CHIREC Rue Wayez, 35 1420 Braine l'Alleud, Belgium https://orcid.org/0000-0002-2574-591X
  • Ilias Bennouna Hopital de Braine L'Alleud, CHIREC Rue Wayez, 35 1420 Braine l'Alleud, Belgium

DOI:

https://doi.org/10.59667/sjoranm.v18i1.14

Keywords:

cerebral hyperperfusion, carotid endarterectomy, complication

Abstract

Introduction: Cerebral hyperperfusion syndrome (CHS) is a rare but potentially fatal complication following carotid revascularization procedures, particularly carotid endarterectomy (CEA), which is commonly used to treat extracranial carotid stenosis, which is a cause of approximately 15% of all strokes. CHS is characterized by non-ischemic headaches, seizures, and neurological deficits.

Case Report: A 73-year-old woman presented with convulsions three days after undergoing a left CEA for 97% stenosis. Initial symptoms included blurred vision, vertigo, and facial paralysis. Imaging revealed left cerebral hemisphere hypervascularization on CT and vasogenic oedema on MRI, consistent with CHS. Despite clinical deterioration, the patient fully recovered following corticosteroid treatment and was discharged without sequelae.

Discussion: CHS symptoms range from mild headaches to seizures and coma. Although uncommon, the condition carries a high risk of mortality. Pathophysiology involves impaired cerebral autoregulation due to chronic ischemia. Diagnosis relies on imaging, though no standardized criteria exist.

Conclusion: Given its delayed onset and potentially devastating consequences, CHS must be considered in post-CEA or stenting patients. Early recognition and management are essential to prevent adverse outcomes.

References

1. Huibers AE, Westerink J, de Vries EE, et al. Editor’s Choice – Cerebral Hyperperfusion Syndrome After Carotid Artery Stenting: A Systematic Review and Meta-analysis. European Journal of Vascular and Endovascular Surgery. Elsevier Ltd; 2018;56(3):322–333. doi: https://doi.org/10.1016/j.ejvs.2018.05.012

2. Lin YH, Liu HM. Update on cerebral hyperperfusion syndrome. J Neurointerv Surg. 2020;12(8):788–793. doi: https://doi.org/10.1136/neurintsurg-2019-015621

3. Wang GJ, Beck AW, DeMartino RR, Goodney PP, Rockman CB, Fairman RM. Insight into the cerebral hyperperfusion syndrome following carotid endarterectomy from the national Vascular Quality Initiative. J Vasc Surg. Society for Vascular Surgery; 2017;65(2):381-389.e2. doi: https://doi.org/10.1016/j.jvs.2016.07.122

4. Fan X, Zuo Z, Lin T, et al. Arterial transit artifacts on arterial spin labeling MRI can predict cerebral hyperperfusion after carotid endarterectomy: an initial study. Eur Radiol. European Radiology; 2022;32(9):6145–6157. doi: https://doi.org/10.1007/s00330-022-08755-x

Published

2025-04-30

How to Cite

Cerebral hyperperfusion syndrome following carotid endarterectomy. (2025). Swiss Journal of Radiology and Nuclear Medicine, 18(1), 1-5. https://doi.org/10.59667/sjoranm.v18i1.14